SOLV * Stock Overview
A healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 1/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Solventum Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1,418.00 |
52 Week High | US$1,485.00 |
52 Week Low | US$800.00 |
Beta | 0 |
1 Month Change | 1.29% |
3 Month Change | 4.26% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 37.40% |
Recent News & Updates
Recent updates
Shareholder Returns
SOLV * | MX Medical Equipment | MX Market | |
---|---|---|---|
7D | 0% | 0% | 0% |
1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how SOLV * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how SOLV * performed against the MX Market.
Price Volatility
SOLV * volatility | |
---|---|
SOLV * Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: SOLV *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine SOLV *'s volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2023 | 22,000 | Bryan Hanson | www.solventum.com |
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.
Solventum Corporation Fundamentals Summary
SOLV * fundamental statistics | |
---|---|
Market cap | Mex$235.54b |
Earnings (TTM) | Mex$14.68b |
Revenue (TTM) | Mex$167.45b |
16.0x
P/E Ratio1.4x
P/S RatioIs SOLV * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SOLV * income statement (TTM) | |
---|---|
Revenue | US$8.22b |
Cost of Revenue | US$3.58b |
Gross Profit | US$4.63b |
Other Expenses | US$3.91b |
Earnings | US$720.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.17 |
Gross Margin | 56.38% |
Net Profit Margin | 8.76% |
Debt/Equity Ratio | 254.0% |
How did SOLV * perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 15:12 |
End of Day Share Price | 2024/11/22 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Solventum Corporation is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Travis Steed | BofA Global Research |
Travis Steed | BofA Global Research |
Michael Gorman | BTIG |